EyePoint Pharmaceuticals Inc (EYPT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

480 PLEASANT STREET WATERTOWN, MA 02472

Operates as a global nanotechnology company that focuses on the development of BioSilicon, a novel porous form of nano-sized silicon, for therapeutic and diagnostic use in healthcare. BioSilicon is composed of elemental silicon, engineered to create a honeycomb structure of pores.

Data as of 2020-05-30
Market Cap107.278 Million Shares Outstanding124.742 Million Avg 30-day Volume380.071 Thousand
P/E Ratio Dividend Yield EPS-0.46
Price/Sales4.151 Price cash flow ratio10.5 Price free cash flow ratio-1.8
Book Value0.13 Price to Tangible Book-10.03 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.06356
BETA1.36296 52-week High/Low2.69 / 0.7 Stddev0.231111
View SEC Filings from EYPT instead.

View recent insider trading info

Funds Holding EYPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EYPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GODSHALL DOUGLAS EVAN PRESIDENT & CEO

  • Officer
  • Director
98,359 2020-05-15 3

DUKER JAY S.

  • Director
0 2020-05-06 3

ANDO GORAN

  • Director
0 2020-04-24 2

FREEDMAN LORI VP AND GENERAL COUNSEL

  • Officer
26,918 2020-04-22 0

MAZZO DAVID J

  • Director
0 2020-04-03 5

EW HEALTHCARE PARTNERS, L.P.

EW HEALTHCARE PARTNERS-A, L.P.

ESSEX WOODLANDS FUND IX-GP, L.P.

ESSEX WOODLANDS IX, LLC

  • 10% Owner
0 2020-03-18 0

ELSTON GEORGE CHIEF FINANCIAL OFFICER

20,000 2020-03-12 4

LURKER NANCY PRESIDENT & CEO

574,800 2020-03-10 7

PAGGIARINO DARIO A. CHIEF MEDICAL OFFICER

0 2020-02-28 5

PETERSON KRISTINE

0 2020-02-28 3

LANDIS JOHN B.

0 2020-02-28 2

GUYER DAVID R

0 2020-02-28 1

JONES DAVID SCOTT SVP & CHIEF COMMERCIAL OFFICER

0 2020-02-28 3

DICICCO WENDY F

0 2020-02-28 3

BARRY JAMES J PRESIDENT AND CEO

  • Officer
  • Director
2,166,382 2019-12-16 0

JORN DEBORA

  • Director
0 2019-11-26 0

ROSS LEONARD S SEE REMARKS

90,044 2019-06-27 2

ROGERS MICHAEL W

0 2019-06-25 2

PRICE DAVID CFO

0 2019-06-25 1

EASTMAN RONALD W

  • Director
  • 10% Owner
No longer subject to file 2018-11-27 0

BLUM LEONARD M SEE REMARKS

  • Officer
0 2018-05-14 0

ASHTON PAUL PRESIDENT & CEO

  • Officer
  • Director
467,522 2016-03-18 0

SAVAS PETER G

  • Director
0 2015-12-03 0

HOPPER PAUL

  • Director
0 2013-12-18 0

SOJA MICHAEL VP FINANCE, CFO & TREASURER

  • Officer
0 2008-09-10 0

WOODTHORPE KATHERINE

  • Director
0 2008-06-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Squarepoint Ops LLC EyePoint Pharmaceuticals Inc 0.6% 2019-11-05 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC EyePoint Pharmaceuticals Inc 0.5% 2019-10-16 GERMANY

Elevate your investments